EP2542886A1 - Système et procédé de surveillance d'au moins un paramètre sanguin - Google Patents

Système et procédé de surveillance d'au moins un paramètre sanguin

Info

Publication number
EP2542886A1
EP2542886A1 EP11706276A EP11706276A EP2542886A1 EP 2542886 A1 EP2542886 A1 EP 2542886A1 EP 11706276 A EP11706276 A EP 11706276A EP 11706276 A EP11706276 A EP 11706276A EP 2542886 A1 EP2542886 A1 EP 2542886A1
Authority
EP
European Patent Office
Prior art keywords
blood
data
patient
identification element
parameters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP11706276A
Other languages
German (de)
English (en)
Inventor
Hans-Otto Maier
Torsten DÖNHOFF
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B Braun Melsungen AG
Original Assignee
B Braun Melsungen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Braun Melsungen AG filed Critical B Braun Melsungen AG
Publication of EP2542886A1 publication Critical patent/EP2542886A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/08—Sensors provided with means for identification, e.g. barcodes or memory chips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150229—Pumps for assisting the blood sampling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150236—Pistons, i.e. cylindrical bodies that sit inside the syringe barrel, typically with an air tight seal, and slide in the barrel to create a vacuum or to expel blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150244—Rods for actuating or driving the piston, i.e. the cylindrical body that sits inside the syringe barrel, typically with an air tight seal, and slides in the barrel to create a vacuum or to expel blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150389—Hollow piercing elements, e.g. canulas, needles, for piercing the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150503—Single-ended needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150763—Details with identification means
    • A61B5/150786—Optical identification systems, e.g. bar codes, colour codes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/155—Devices specially adapted for continuous or multiple sampling, e.g. at predetermined intervals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6009—General characteristics of the apparatus with identification means for matching patient with his treatment, e.g. to improve transfusion security
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584—Control arrangements for automatic analysers
    • G01N35/00722—Communications; Identification
    • G01N35/00871—Communications between instruments or with remote terminals
    • G01N2035/00881—Communications between instruments or with remote terminals network configurations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection

Definitions

  • the invention relates to a system and a method for monitoring at least one blood parameter of the blood from a predetermined patient with an access device for establishing access to the blood of the patient, a withdrawal device for taking a quantity of blood for obtaining a blood sample, a blood analysis device for analyzing the A blood sample and a calculating device for calculating medicament parameters of a medicament to be administered to the patient and a delivery device for supplying the medicament with the calculated medicament parameters according to the preamble of patent claim 1 and the preamble of patent claim 9.
  • Systems for collecting blood and for monitoring at least one blood parameter of the blood from a predetermined patient are known in many ways. For example, there are systems which monitor the glucose value of the blood as relevant blood parameters in order to supply a corresponding amount of insulin as a medicament to the patient in response to the determined glucose value after calculation of an insulin value.
  • patients in particular in the intensive care unit, are supplied with medicaments and possibly artificial food by means of one or more delivery devices, for example intravenously or by means of a stomach tube.
  • the delivery device may be an insulin delivery device or an infusion pump which adjusts the insulin value present within the bloodstream of the patient to a predefined value. res in response to a previously measured blood glucose level in the patient's bloodstream.
  • feeding devices for at least one nutritional value of a food directly or indirectly supplied with at least one food supply device in the bloodstream can be administered to the patient.
  • All such delivery devices even when incorporated into a drug and / or nutritional delivery system, heretofore require the entry of values by a physician or other clinician based on delivery by the delivery device. For example, quantity values, time intervals in which the supply should take place, interval-type delivery, etc., can be entered as the basis for the subsequent delivery of, for example, insulin.
  • the central idea of the invention is that in a system for monitoring at least one blood parameter of the blood from a predetermined patient with the following devices access means for establishing access to the patient's blood through the skin thereof;
  • a sampling device for taking a quantity of blood to obtain a blood sample
  • a blood analyzer useful for a plurality of blood samples from different patients for analyzing the blood sample for predeterminable parameters of the blood
  • a first calculation device for calculating drug parameters of a drug to be administered to the patient on the basis of the determined parameters of the analyzed blood
  • an identification element generating device which has the function of generating the identification element, which is, for example, a barcode or a data matrix code in two-dimensional or three-dimensional form, or a transponder, in order subsequently to arrange this on the removal device.
  • data which is also patient or personal and may also represent treatment-related data by means of a determination or calculation device, such as a PC with an input keyboard or a PC with a reader connected thereto, for a barcode scanner in the blood analysis be input device and compared with the data of the identification element, which is for example a bar code, and is read out by means of the blood analyzer.
  • a determination or calculation device such as a PC with an input keyboard or a PC with a reader connected thereto
  • the data of the identification element which is for example a bar code
  • Such a determination or reading of the personal and treatment-related data can advantageously take place by means of a barcode scanner, which scans the bracelet of a patient who has such a barcode and reads in the barcode.
  • the scanned barcode is then subsequently printed out by means of a printing device or the identification element generating device and mounted on the syringe or on the other container.
  • the attachment particularly preferably takes place on the blood receptacle of the syringe on the outside by means of an adhesive surface or a blood receptacle connected thereto.
  • the read-in barcode is converted by means of a second calculation device as personal and treatment-related data and determined accordingly in order subsequently to pass on this data to the blood analysis device for comparison purposes.
  • the data received in the second calculation device are the scanned data of another identification element or the data entered by means of a keyboard for the person and the treatment of the patient.
  • the personal and treatment-related data are encrypted on the identification element.
  • the data may include information at the predeterminable time of the blood sample to be taken, the name of the patient and the drug, the dose of medicament to be administered, and the like data.
  • the blood parameters to be determined for the blood to be analyzed can
  • Glucose levels, pH values, coagulation factors of the blood and other blood gas data such as C0 2 values, P0 2 values, potassium values, bicarbonate values,
  • Other data that may be included on or in the identifier attached to the blood sample or attached to the syringe may include blood collection time, blood collection date, summer or winter time, and the like be.
  • data on the type of blood can be introduced into the identification element of the blood sample.
  • all the data are passed on to the blood analysis device comprehensively, with data such as information about the time of day, the date and the summer or winter time also being able to be generated by means of the second calculation device on receipt of the personal and treatment-related data and forwarded to the blood analysis device.
  • the blood analysis device is connected to the first calculation device and this with the supply device for supplying the drug such that a data transfer can take place. This can be done both wired and wireless.
  • the various devices may be located at different locations, and a high degree of automation in the automatic delivery of medication, even in ICU patients, will be obtained based on measurements and patient-induced parameters.
  • the blood parameter to be determined may be glucose and the drug to be administered may be insulin and the delivery means may be an insulin pump: - establishing access to the patient's blood through the skin thereof by means of the access device;
  • the blood sample is assigned to at least one identification element with personal and treatment-related data immediately after removal of the blood quantity and before delivery from the blood analysis device by means of an identification element generating device in order to obtain an automated identification.
  • the method also comprises reading personal and treatment-related data of the identification element by means of a reading unit, which is preferably connected to or arranged within the blood analysis device, and associating the read-out data with the blood to be analyzed within the blood analysis device by means of an allocation unit.
  • Fig. 1 is a schematic representation of the system and its operation in an embodiment of the invention
  • FIGS. 2a and 2b are a flowchart showing the method according to an embodiment of the invention.
  • Fig. 1 the system of the invention according to an embodiment of the invention is shown in a schematic representation. It can be seen from this illustration that in a patient 1, of whom a hand and an arm are shown, a needle 2 as an access device penetrates through a skin in order to draw blood.
  • the blood collection takes place, for example, by means of a syringe 3 as a removal device in the usual manner known.
  • a barcode scanner 5 which is connected to a reading device 6, a bracelet 4, on which a barcode is mounted, is scanned.
  • This barcode contains personal and treatment-specific data of the patient wearing this bracelet. For example, this may include the name of the patient, the name of the drug to be administered, age, and other personal information.
  • the reading device 6 sends a corresponding barcode signal to a calculation device 7, which has the task of determining the relevant personal and treatment-specific data, including the time of the blood withdrawal, from the barcode read in, and this Data to an identification element generating device 9, which can represent a bar code printer, continue to send.
  • This printer 9 prints out a barcode with the personal and treatment-specific data and this barcode is glued, for example in the form of a barcode label 10, onto the blood sample receptacle of the syringe 3.
  • the calculation device 7 sends the ascertained person-specific and treatment-specific data to a comparison unit 15 within a blood analysis device 12.
  • person-specific and treatment-specific data can be entered into the calculation device 7 by means of a keyboard 8 in order to include these in the barcode to be printed or in the comparison unit 15 with to consider.
  • the blood present in the syringe 7 is taken up by the blood analyzer 12 for analysis.
  • the blood analyzer 12 there is a scanning of the barcode 10 by another Barcode scanner 13 instead, which is connected to a reading unit 14 within the blood analyzer 12.
  • the read barcode data are in turn converted into person-specific and treatment-specific electronic data and forwarded to the comparison unit 15.
  • the comparison unit 15 the data which has been read out by the barcode scanner 13 at the barcode 10 are compared with the data resulting from the calculation device 7. As soon as such a comparison identifies similarities in the data, an assignment of these personal and treatment-related data to the blood sample 3 takes place. This is done by an allocation unit 16.
  • the actual analysis of the blood to be analyzed and then the determination of one or more desired blood parameter values take place within an analysis unit 17.
  • the glucose value can be determined within the blood taken to then administer insulin as the drug in the desired level, which corresponds to the drug parameters.
  • data representing the analysis measurement values and containing, for example, the level of a glucose value are transmitted to a calculation device 18, which has the task of using an internal database and a corresponding memory unit to add the corresponding medication to the corresponding dose To determine glucose value.
  • a height of the insulin to be administered is determined by means of the calculation device 18.
  • a transfer of data representing the amount of the insulin value and the amount of the insulin value takes place to a delivery device 19, which in this case is designed as an insulin pump.
  • This insulin pump 19 leads via a catheter 20 insulin to the patient 1 in the desired amount and in the desired time.
  • Fig. 2a and 2b the inventive method according to an embodiment of the invention is shown. From this representation it can be seen that in a step 21 the scanning NEN of a barcode on the bracelet of the patient by means of a barcode scanner and the determination of data by means of the second calculation device 7 takes place.
  • a step 22 the printing of a barcode label is carried out by means of the printer 9. Subsequent application of the barcode label to the blood sample vessel takes place in a step 23.
  • the blood sample is then introduced into a blood analysis device in a step 24, whereupon the bar code label is read in step 25 by a barcode scanner of the blood analysis device.
  • step 26 After the data of the bar code label and the determined data are compared in the comparison unit 15 according to step 26, it is determined in a query 27 whether these are identical. If this is not the case, according to step 28, no analysis is possible and the process is finished.
  • step 29 and step 30 the data of the blood sample to be analyzed and the blood sample are analyzed.
  • the determined parameters of the blood of the analyzed blood sample have been sent to a first calculation device, in a step 32 the drug parameters are calculated by this calculation device. These are, for example, the amount and duration of administration of the drug insulin.
  • a signal is then sent to the pump 19 on the basis of the determined drug parameter, which in a step 34 administers the drug in the desired amount and the desired time interval to the patient.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Manufacturing & Machinery (AREA)
  • Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Mobile Radio Communication Systems (AREA)

Abstract

L'invention concerne un système et un procédé de surveillance d'au moins un paramètre sanguin du sang d'un patient déterminé (1), ledit système comportant un dispositif d'accès pour la mise en place d'un accès au sang du patient, un dispositif de prélèvement (3) pour le prélèvement d'une quantité de sang en vue d'obtenir un échantillon sanguin, un dispositif d'analyse sanguine (12) pour l'analyse de l'échantillon sanguin et un dispositif de calcul (18) pour le calcul de paramètres de médicament d'un médicament à administrer au patient, ainsi qu'un dispositif d'alimentation (19) pour la fourniture du médicament à l'aide des paramètres de médicament calculés. Le système identifie au moyen de codes-barres (10, 4) les échantillons sanguins, ce qui empêche toute erreur dans l'affectation du sang à analyser au patient concerné. L'invention concerne un système et un procédé de surveillance d'au moins un paramètre sanguin du sang d'un patient déterminé, ledit système comportant un dispositif d'accès pour la mise en place d'un accès au sang du patient, un dispositif de prélèvement pour le prélèvement d'une quantité de sang en vue d'obtenir un échantillon sanguin, un dispositif d'analyse sanguine pour l'analyse de l'échantillon sanguin et un dispositif de calcul pour le calcul de paramètres de médicament d'un médicament à administrer au patient, ainsi qu'un dispositif d'alimentation pour la fourniture du médicament à l'aide des paramètres de médicament calculés.
EP11706276A 2010-03-05 2011-03-03 Système et procédé de surveillance d'au moins un paramètre sanguin Ceased EP2542886A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102010010567 2010-03-05
DE102010012733 2010-03-24
PCT/EP2011/053248 WO2011107571A1 (fr) 2010-03-05 2011-03-03 Système et procédé de surveillance d'au moins un paramètre sanguin

Publications (1)

Publication Number Publication Date
EP2542886A1 true EP2542886A1 (fr) 2013-01-09

Family

ID=43920342

Family Applications (6)

Application Number Title Priority Date Filing Date
EP11706275A Ceased EP2542991A1 (fr) 2010-03-05 2011-03-03 Système et procédé permettant de surveiller l'intervalle de temps lors d'opérations de surveillance de paramètres sanguins
EP11706274A Ceased EP2542276A1 (fr) 2010-03-05 2011-03-03 Système et méthode d'administration de médicaments à un patient
EP11706599.5A Active EP2542142B1 (fr) 2010-03-05 2011-03-03 Système d'administration de médicaments avec prise en compte de valeurs urinaires
EP11706276A Ceased EP2542886A1 (fr) 2010-03-05 2011-03-03 Système et procédé de surveillance d'au moins un paramètre sanguin
EP11707397.3A Active EP2542992B1 (fr) 2010-03-05 2011-03-03 Système de transmission de données dans la determination de parametres de médicaments
EP11707651.3A Not-in-force EP2542151B1 (fr) 2010-03-05 2011-03-03 Système de détermination de données thérapeutiques pour l'administration de médicaments à des patients à traiter avec prise en compte de facteurs de coefficient individuels

Family Applications Before (3)

Application Number Title Priority Date Filing Date
EP11706275A Ceased EP2542991A1 (fr) 2010-03-05 2011-03-03 Système et procédé permettant de surveiller l'intervalle de temps lors d'opérations de surveillance de paramètres sanguins
EP11706274A Ceased EP2542276A1 (fr) 2010-03-05 2011-03-03 Système et méthode d'administration de médicaments à un patient
EP11706599.5A Active EP2542142B1 (fr) 2010-03-05 2011-03-03 Système d'administration de médicaments avec prise en compte de valeurs urinaires

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP11707397.3A Active EP2542992B1 (fr) 2010-03-05 2011-03-03 Système de transmission de données dans la determination de parametres de médicaments
EP11707651.3A Not-in-force EP2542151B1 (fr) 2010-03-05 2011-03-03 Système de détermination de données thérapeutiques pour l'administration de médicaments à des patients à traiter avec prise en compte de facteurs de coefficient individuels

Country Status (14)

Country Link
US (6) US20120323215A1 (fr)
EP (6) EP2542991A1 (fr)
JP (6) JP5485414B2 (fr)
CN (5) CN102762144B (fr)
AU (6) AU2011222945B2 (fr)
BR (6) BR112012019624A2 (fr)
CA (6) CA2787324C (fr)
ES (2) ES2904601T3 (fr)
IL (6) IL220765B (fr)
MX (6) MX2012008822A (fr)
PL (1) PL2542142T3 (fr)
RU (6) RU2526141C2 (fr)
SG (6) SG182546A1 (fr)
WO (6) WO2011107571A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10089443B2 (en) 2012-05-15 2018-10-02 Baxter International Inc. Home medical device systems and methods for therapy prescription and tracking, servicing and inventory
US9514131B1 (en) * 2010-05-30 2016-12-06 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification
US10492991B2 (en) 2010-05-30 2019-12-03 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification
US10262112B2 (en) 2013-02-04 2019-04-16 Precera Bioscience, Inc. Prescription decision support system and method using comprehensive multiplex drug monitoring
DE102014105058A1 (de) * 2014-04-09 2015-10-15 Stephanie Ittstein Vorrichtung zu einer Herstellung und/oder zu einer Verabreichung
JP6391312B2 (ja) * 2014-06-13 2018-09-19 クラリオン株式会社 端末接続装置、処理情報実行システム、及び処理情報実行方法
EP3539586B1 (fr) 2014-10-10 2022-08-24 NxStage Medical Inc. Procédés d'équilibrage de flux
US11714975B2 (en) 2014-10-28 2023-08-01 Avery Dennison Retail Information Services Llc High density read chambers for scanning and encoding RFID tagged items
US20160314185A1 (en) * 2015-04-27 2016-10-27 Microsoft Technology Licensing, Llc Identifying events from aggregated device sensed physical data
DE102016005131A1 (de) * 2016-04-27 2017-11-02 Justus-Liebig-Universität Giessen Vorrichtung und Verfahren zur Verhinderung von Fehlzuleitungen eines Arzneimittels
US10045725B2 (en) * 2016-05-13 2018-08-14 Hugh Califf Blood analysis method and apparatus
CA3024943A1 (fr) * 2016-05-20 2017-11-23 Magna Exteriors Inc. Systemes de panneau de soubassement de carrosserie actif
WO2018017623A1 (fr) 2016-07-18 2018-01-25 Nxstage Medical, Inc. Dispositifs, procédés, et systèmes d'équilibrage de débits
US11865243B2 (en) 2016-08-30 2024-01-09 Nxstage Medical, Inc. Parameter monitoring in medical treatment systems
RU2741629C2 (ru) * 2016-09-20 2021-01-28 Бракко Дайэгностикс Инк. Системы и способы производства, инфузионного ввода и контроля доставки радиоактивного изотопа
SG11202009326XA (en) 2018-03-28 2020-10-29 Bracco Diagnostics Inc Early detection of radioisotope generator end life
US12170153B2 (en) 2018-03-28 2024-12-17 Bracco Diagnostics Inc. Systems and techniques for calibrating radioisotope delivery systems with a gamma detector
EP3669912A1 (fr) * 2018-12-19 2020-06-24 Sanofi Dispositif pour l'administration de médicaments et système pour l'administration de médicaments
WO2020237228A1 (fr) 2019-05-23 2020-11-26 Nxstage Medical, Inc. Dispositifs, procédés, et systèmes de synchronisation d'écoulement
CN115104159A (zh) 2020-02-21 2022-09-23 布拉科诊断公司 放射性同位素发生器早期突破检测
WO2021192971A1 (fr) * 2020-03-27 2021-09-30 テルモ株式会社 Dispositif d'estimation de fonction biologique, et procédé d'estimation de fonction biologique
TWI811641B (zh) * 2021-03-04 2023-08-11 宏碁股份有限公司 用藥風險評估方法與用藥風險評估裝置
DE102021127476A1 (de) * 2021-10-22 2023-04-27 B. Braun Melsungen Aktiengesellschaft System und Verfahren zur Bereitstellung einer Medikation an einem medizinischen Gerät
WO2023101996A1 (fr) * 2021-11-30 2023-06-08 Tandem Diabetes Care, Inc. Schéma d'autorisations et d'attribution de priorité de bolus pour système de pompe à perfusion
IT202200022275A1 (it) * 2022-10-28 2024-04-28 Datamed S R L Dispositivo e metodo per misurare una pluralità di parametri del sangue mediante intelligenza artificiale

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139701A1 (en) * 1999-12-01 2003-07-24 B. Braun Medical, Inc. Security infusion pump with bar code reader

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151845A (en) * 1977-11-25 1979-05-01 Miles Laboratories, Inc. Blood glucose control apparatus
JPS5521905A (en) * 1978-08-02 1980-02-16 Nikkiso Co Ltd Improvement of artificial pancreas
US4449538A (en) * 1982-01-25 1984-05-22 John Corbitt Medical-electronic body fluid accounting system
SU1458824A1 (ru) * 1987-02-19 1989-02-15 Московский медицинский стоматологический институт им.Н.А.Семашко Способ определени нарушени активности фибриногена плазмы крови
SU1686361A1 (ru) * 1988-04-05 1991-10-23 Самарский медицинский институт им.Д.И.Ульянова Способ определени функциональной активности клеток крови доноров
US5956501A (en) 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
US5590648A (en) * 1992-11-30 1997-01-07 Tremont Medical Personal health care system
CA2175584C (fr) * 1993-11-02 2005-07-12 Michael Kell Methode de controle de l'observation par un patient des prescriptions medicales
JP3243103B2 (ja) * 1994-02-04 2002-01-07 吉彦 鈴木 血糖値の制御装置
US7384410B2 (en) * 1995-03-13 2008-06-10 Cardinal Health 303, Inc. System and method for managing patient care
US5713856A (en) * 1995-03-13 1998-02-03 Alaris Medical Systems, Inc. Modular patient care system
JPH09329597A (ja) * 1996-06-11 1997-12-22 Hitachi Ltd 尿沈渣検査システム
JPH10274656A (ja) * 1997-03-28 1998-10-13 Kdk Corp グルコース濃度の測定方法
US6579690B1 (en) * 1997-12-05 2003-06-17 Therasense, Inc. Blood analyte monitoring through subcutaneous measurement
US7760187B2 (en) * 2004-07-30 2010-07-20 Apple Inc. Visual expander
US8480580B2 (en) * 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6074345A (en) * 1998-10-27 2000-06-13 University Of Florida Patient data acquisition and control system
RU2148257C1 (ru) 1999-06-01 2000-04-27 Тверская государственная медицинская академия Способ исследования крови
US6423035B1 (en) * 1999-06-18 2002-07-23 Animas Corporation Infusion pump with a sealed drive mechanism and improved method of occlusion detection
US6790198B1 (en) * 1999-12-01 2004-09-14 B-Braun Medical, Inc. Patient medication IV delivery pump with wireless communication to a hospital information management system
US20030154108A1 (en) * 2000-03-01 2003-08-14 Gambro, Inc. Extracorporeal blood processing information management system
JP2001245874A (ja) * 2000-03-03 2001-09-11 Sefa Technology Kk 赤血球沈降速度測定用採血管、採血管ホルダ、採血管運搬用プロテクタ、赤血球沈降速度測定方法およびその測定装置
DE10011395A1 (de) * 2000-03-09 2001-09-20 Braun Melsungen Ag Fluid-Bilanzierungssystem
US7630908B1 (en) * 2000-05-01 2009-12-08 John Amrien Wireless electronic prescription scanning and management system
GB0030809D0 (en) * 2000-12-16 2001-01-31 Schmidt Paul Sample tracking systems
US6973374B2 (en) * 2000-12-19 2005-12-06 University Of Rochester Method and device for administering medication and/or placebo
JP4276834B2 (ja) * 2000-12-27 2009-06-10 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 生体情報及び血液処理装置情報管理システム
US20030013972A1 (en) * 2001-05-29 2003-01-16 Makin Inder Raj. S. Treatment of lung lesions using ultrasound
KR100954253B1 (ko) * 2001-11-30 2010-04-23 브리티쉬 텔리커뮤니케이션즈 파블릭 리미티드 캄퍼니 데이터 전송 시스템, 동작 방법 및 디지털 미디어 캐리어
RU2226689C2 (ru) * 2001-12-27 2004-04-10 Медицинский радиологический научный центр РАМН Способ определения сопротивляемости организма
US20030141981A1 (en) * 2002-01-29 2003-07-31 Tuan Bui System and method for operating medical devices
US20030212379A1 (en) * 2002-02-26 2003-11-13 Bylund Adam David Systems and methods for remotely controlling medication infusion and analyte monitoring
DE10226212A1 (de) 2002-06-13 2003-12-24 Philips Intellectual Property Eignungsprüfungssystem
DE20217847U1 (de) * 2002-11-19 2004-04-08 B. Braun Melsungen Ag Sekretsammelvorrichtung
US20040172284A1 (en) * 2003-02-13 2004-09-02 Roche Diagnostics Corporation Information management system
ZA200508816B (en) * 2003-04-23 2008-01-30 Vasogen Ireland Ltd Dispensing systems
KR20060005389A (ko) * 2003-04-23 2006-01-17 바소겐 아일랜드 리미티드 주사 시스템
US7258673B2 (en) * 2003-06-06 2007-08-21 Lifescan, Inc Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein
US8998808B2 (en) * 2003-06-19 2015-04-07 Wayne State University System for identifying patient response to anesthesia infusion
US20050019943A1 (en) 2003-07-09 2005-01-27 Chaoui Sam M. Automatic blood analysis and identification system
US20050021367A1 (en) * 2003-07-25 2005-01-27 Deborah Saeger Medication administration system
US20050021368A1 (en) * 2003-07-25 2005-01-27 Debra Burkeen Enhanced safety medication administration system
JP2005102960A (ja) * 2003-09-30 2005-04-21 Seiko Epson Corp 点滴支援システム、点滴支援装置および点滴装置、並びに点滴方法
WO2005050497A1 (fr) * 2003-11-21 2005-06-02 Vasogen Ireland Limited Systemes de gestion de traitements medicaux
US20050154368A1 (en) * 2003-11-21 2005-07-14 Vasogen Ireland Limited Medical material handling systems
TW200519382A (en) * 2003-11-21 2005-06-16 Vasogen Ireland Ltd Medical material handling systems
US7172115B2 (en) * 2004-04-02 2007-02-06 Riptide Systems, Inc. Biometric identification system
US8518021B2 (en) * 2004-05-27 2013-08-27 Baxter International Inc. Apparatus and method for therapeutic delivery of medication
US8359338B2 (en) * 2004-07-30 2013-01-22 Carefusion 303, Inc. System and method for managing medical databases for patient care devices
JP2008516641A (ja) * 2004-08-23 2008-05-22 リモート クリニカル ソリューションズ インコーポレイテッド 経口投与するための流体を変更するためのシステム及び方法
US20060081257A1 (en) * 2004-08-31 2006-04-20 Ross Krogh Single use drug delivery components
US7727222B2 (en) * 2004-09-09 2010-06-01 Plc Medical Systems, Inc. Patient hydration system with taper down feature
US20080027409A1 (en) * 2004-09-09 2008-01-31 Rudko Robert I Patient hydration/fluid administration system and method
RU2275640C1 (ru) * 2004-09-20 2006-04-27 Илья Николаевич Медведев Способ выбора метода лечения тромбоцитопатии при метаболическом синдроме
SG158906A1 (en) 2005-02-11 2010-02-26 Cardinal Health 303 Inc Identification system and method for medication management
US7785258B2 (en) * 2005-10-06 2010-08-31 Optiscan Biomedical Corporation System and method for determining a treatment dose for a patient
US8956291B2 (en) * 2005-02-22 2015-02-17 Admetsys Corporation Balanced physiological monitoring and treatment system
US7509156B2 (en) 2005-05-18 2009-03-24 Clarian Health Partners, Inc. System for managing glucose levels in patients with diabetes or hyperglycemia
KR100716015B1 (ko) * 2005-06-08 2007-05-08 유재천 란셋 장치 및 이를 이용한 혈액의 채취 및 주입 방법
US20070088333A1 (en) * 2005-10-13 2007-04-19 G&L Consulting, Llc Method and system for infusing an osmotic solute into a patient and providing feedback control of the infusing rate
US20070100256A1 (en) * 2005-10-28 2007-05-03 Sansom Gordon G Analyte monitoring system with integrated lancing apparatus
US8543420B2 (en) * 2007-09-19 2013-09-24 Fresenius Medical Care Holdings, Inc. Patient-specific content delivery methods and systems
US8140353B2 (en) 2006-06-29 2012-03-20 The Invention Science Fund I, Llc Compliance data for health-related procedures
US9015055B2 (en) * 2006-07-13 2015-04-21 Abbott Point Of Care Inc. Medical data acquisition and patient management system and method
CN1987962A (zh) * 2006-09-27 2007-06-27 上海博维康讯信息科技发展有限公司 一种一次性病人腕带及病人身份识别系统
RU2316765C1 (ru) * 2006-09-28 2008-02-10 Илья Николаевич Медведев Способ раннего выявления ослабления антитромботической активности сосудов
RU2328000C1 (ru) * 2006-11-27 2008-06-27 Илья Николаевич Медведев Способ раннего выявления тромбопластинообразования
KR101099321B1 (ko) * 2006-12-22 2011-12-26 가부시키가이샤 코나미 데지타루 엔타테인멘토 두 명 이상의 플레이어가 즐길 수 있는 장난감 총
EP2139541B1 (fr) * 2007-01-01 2018-04-11 Bayer Healthcare LLC Systèmes permettant la génération, la préparation, le transport et l'administration radiopharmaceutiques intégrés
JP2008224385A (ja) 2007-03-12 2008-09-25 Olympus Corp 分析装置および分析方法
EP2131723B1 (fr) * 2007-03-19 2013-07-24 Insuline Medical Ltd. Dispositif pour mesure de substance
US8417311B2 (en) * 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US8412293B2 (en) * 2007-07-16 2013-04-02 Optiscan Biomedical Corporation Systems and methods for determining physiological parameters using measured analyte values
US20080306444A1 (en) 2007-06-08 2008-12-11 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US20090004317A1 (en) * 2007-06-30 2009-01-01 Xuejiao Hu High thermal conductivity molding compound for flip-chip packages
WO2009029899A1 (fr) * 2007-09-01 2009-03-05 Sang Hoon Woo Contrôle de condition de liquides organiques à l'aide de diurétiques
CN102670209A (zh) * 2007-09-07 2012-09-19 泰尔茂株式会社 血糖值测量方法
DE102007047351A1 (de) * 2007-10-02 2009-04-09 B. Braun Melsungen Ag System und Verfahren zur Überwachung und Regelung von Blutglukosewerten
CA2702116C (fr) 2007-10-10 2021-01-05 Optiscan Biomedical Corporation Systeme d'analyse de composant de fluide et procede pour controler et reguler le glucose
JP5188780B2 (ja) * 2007-11-08 2013-04-24 日機装株式会社 血液浄化装置及びそれによる治療終了の報知方法
RU2371723C1 (ru) * 2008-03-03 2009-10-27 Государственное учреждение Научный центр реконструктивной и восстановительной хирургии Восточно-Сибирского научного центра Сибирского отделения Российской Академии медицинских наук Способ оценки устойчивости эритроцитов к функциональной нагрузке
JP2009273502A (ja) 2008-05-12 2009-11-26 Jms Co Ltd 投薬監視装置
US20090307008A1 (en) * 2008-06-04 2009-12-10 Cardinalhealth Blood infusion management system and method
US20100036310A1 (en) * 2008-08-05 2010-02-11 Hillman Robert S Integrated patient management and control system for medication delivery
US20100160854A1 (en) * 2008-12-22 2010-06-24 Gauthier Robert T Integrated patient management and control system for medication delivery

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139701A1 (en) * 1999-12-01 2003-07-24 B. Braun Medical, Inc. Security infusion pump with bar code reader

Also Published As

Publication number Publication date
RU2012133280A (ru) 2014-02-10
SG183353A1 (en) 2012-09-27
CA2788057C (fr) 2014-12-02
RU2530590C2 (ru) 2014-10-10
RU2522270C2 (ru) 2014-07-10
BR112012021524B1 (pt) 2021-10-13
CA2788603A1 (fr) 2011-09-09
AU2011222945B2 (en) 2014-02-06
JP2013520718A (ja) 2013-06-06
JP5758409B2 (ja) 2015-08-05
CA2789191A1 (fr) 2011-09-09
EP2542142A1 (fr) 2013-01-09
IL221166A0 (en) 2012-09-24
JP2013521543A (ja) 2013-06-10
EP2542992A1 (fr) 2013-01-09
AU2011222943B2 (en) 2014-08-28
EP2542991A1 (fr) 2013-01-09
AU2011222944A1 (en) 2012-08-30
CA2788057A1 (fr) 2011-09-09
CN102834048A (zh) 2012-12-19
AU2011222942A1 (en) 2012-08-30
SG182546A1 (en) 2012-08-30
SG183254A1 (en) 2012-09-27
BR112012020270B1 (pt) 2022-02-15
RU2012134289A (ru) 2014-02-27
RU2524121C2 (ru) 2014-07-27
BR112012020923A2 (pt) 2020-01-14
US20120323141A1 (en) 2012-12-20
PL2542142T3 (pl) 2022-03-21
JP5592506B2 (ja) 2014-09-17
AU2011222947B2 (en) 2014-09-18
IL220765A0 (en) 2012-08-30
RU2012132703A (ru) 2014-02-10
CA2789191C (fr) 2017-10-31
RU2517562C2 (ru) 2014-05-27
AU2011222943A1 (en) 2012-08-30
CN102804191A (zh) 2012-11-28
CN102762240A (zh) 2012-10-31
MX2012009598A (es) 2012-09-12
RU2543941C2 (ru) 2015-03-10
AU2011222946A1 (en) 2012-08-16
IL221166B (en) 2018-06-28
US20130085471A1 (en) 2013-04-04
BR112012017543A2 (pt) 2016-06-28
JP5485414B2 (ja) 2014-05-07
RU2012127707A (ru) 2014-01-20
IL221009A (en) 2017-05-29
EP2542151A1 (fr) 2013-01-09
JP2013519481A (ja) 2013-05-30
CN102834048B (zh) 2016-03-30
SG183352A1 (en) 2012-09-27
WO2011107569A1 (fr) 2011-09-09
BR112012019133A2 (pt) 2018-03-27
EP2542276A1 (fr) 2013-01-09
IL221413B (en) 2020-07-30
CN102762240B (zh) 2017-03-08
CN102762144A (zh) 2012-10-31
RU2012130366A (ru) 2014-01-27
JP2013517871A (ja) 2013-05-20
RU2526141C2 (ru) 2014-08-20
RU2012134290A (ru) 2014-02-20
AU2011222946B2 (en) 2014-10-02
JP2013517030A (ja) 2013-05-16
EP2542992B1 (fr) 2017-11-08
EP2542142B1 (fr) 2021-11-17
IL221373A0 (en) 2012-10-31
WO2011107571A1 (fr) 2011-09-09
WO2011107566A1 (fr) 2011-09-09
MX2012009058A (es) 2012-09-07
CA2789188A1 (fr) 2011-09-09
SG183118A1 (en) 2012-09-27
BR112012019624A2 (pt) 2016-05-03
IL221412A (en) 2016-07-31
EP2542151B1 (fr) 2015-05-06
CN102741850A (zh) 2012-10-17
WO2011107567A1 (fr) 2011-09-09
MX2012008822A (es) 2012-09-07
CN102762144B (zh) 2015-07-08
IL220765B (en) 2018-04-30
ES2655370T3 (es) 2018-02-19
MX2012009596A (es) 2012-09-12
AU2011222945A1 (en) 2012-09-06
SG183354A1 (en) 2012-09-27
CA2787324A1 (fr) 2011-09-09
CN102713615A (zh) 2012-10-03
US20130023819A1 (en) 2013-01-24
ES2904601T3 (es) 2022-04-05
MX2012009373A (es) 2012-09-12
JP2013520217A (ja) 2013-06-06
WO2011107568A1 (fr) 2011-09-09
AU2011222947A1 (en) 2012-07-26
US20120323215A1 (en) 2012-12-20
US20120316465A1 (en) 2012-12-13
IL221373A (en) 2015-06-30
US9861745B2 (en) 2018-01-09
BR112012020270A2 (pt) 2016-05-03
CA2786302C (fr) 2016-02-23
IL221413A0 (en) 2012-10-31
IL221412A0 (en) 2012-10-31
MX2012008144A (es) 2012-08-03
AU2011222944B2 (en) 2013-12-19
CA2786302A1 (fr) 2011-09-09
CA2789188C (fr) 2020-04-07
CA2787324C (fr) 2018-04-17
CA2788603C (fr) 2017-05-23
US20130023851A1 (en) 2013-01-24
BR112012021524A2 (pt) 2016-07-05
AU2011222942B2 (en) 2014-05-08
JP5658767B2 (ja) 2015-01-28
WO2011107570A1 (fr) 2011-09-09

Similar Documents

Publication Publication Date Title
EP2542886A1 (fr) Système et procédé de surveillance d'au moins un paramètre sanguin
EP1316324B1 (fr) Dispositif pour planifier une infusion
DE102007017552A1 (de) Fallabhängige Krankheitsverlaufsvorhersage bei einem Echtzeit-Überwachungssystem
DE102008016770A1 (de) Verfahren und System zur Unterstützung einer fehlerfreien Scannanwendung
DE3741017A1 (de) Einrichtung zur bildarchivierung und -uebermittlung
EP1881858A1 (fr) Procede et dispositif pour piloter une pluralite de pompes a perfusion
WO2009047178A1 (fr) Système et procédé pour contrôler et réguler des taux de glycémie
DE202019005316U1 (de) Computerprogramm und System zum Verwalten von auf einen Patienten bezogenen Medizindaten
DE102011089620A1 (de) Medizinische Injektionsvorrichtung
DE102013215345A1 (de) Verfahren zur Planung einer Untersuchung
EP2593891B1 (fr) Procédé de surveillance des paramètres médicaux d'un patient
DE102011078711A1 (de) Vaskulare Zugangsvorrichtung mit auslesbarer Speichereinheit
EP2236076B1 (fr) Procédé et système de détermination de la différence entres des valeurs pré- et postprandiales
EP2195758B1 (fr) Système de transport et procédé pour l'administration d'un mélange de solutions médicamenteuses
EP2318968A2 (fr) Procédé de surveillance de l'état médical d'un patient
DE102007048094B4 (de) Verfahren und Vorrichtung zum Feststellen von Wirkungen auf einen Organismus
DE102024201526A1 (de) Verfahren und System zum Bereitstellen einer Kontrastmittelwarnung
DE102023124178A1 (de) IV Systems - Digitales EcoSystem zur Verifikation und Dokumentation einer Infusionsangabe
DE102008059901A1 (de) Verfahren zur Überwachung des medizinischen Zustandes eines Patienten
DE102008034736A1 (de) Verfahren zur Überwachung des medizinischen Zustandes eines Patienten
DE112019002089T5 (de) Arzneimittelverwaltungsvorrichtung, Arzneimittelverwaltungsverfahren und Programm zur Arzneimittelverwaltung
CH715554A2 (de) Verfahren zur Doppelkontrolle bei ambulanter Medikamentenabgabe.
AT500492A1 (de) Rechnerunterstütztes system zur patientenüberwachung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120718

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20130715

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20160704